What role will human factors engineers and return to work professionals play in addressing the needs of cancer survivors in return to work? The National Cancer Institute estimates that there are 10.1 million cancer survivors in the United States. of these, 3.8 million are working age adults (ages 20 to 64) (2005). Due to early detection and treatment improvements, the length of survival has increased. Unfortunately, survivors may experience short term and long term side effects (physical, psychosocial and cognitive changes, and fatigue) from treatment that result in functional limitations that may affect their work productivity or their ability to return or continue in the work place. Although the majority of human factors engineering/ergonomics and return to work research has focused on occupational injuries and illnesses, the application of this information to employment issues encountered by cancer survivors may be extremely beneficial.
Get full access to this article
View all access options for this article.
References
1.
AhlesTASaykinA.Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest. 2001;19(8):812–20.
BradleyCJBednarekHLEmployment patterns of long-term cancer survivors. Psycho-Oncology, 2002;11(3):188–198.
4.
CurtGABreitbartWCellaDGroopmanJEHorningSJItriLMImpact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist, 2000;5: 353–360.
5.
DownieFPFanMar HGHouede-TchenNYiQTannockIFCognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psycho-Oncology, 2006.
6.
FeuersteinM.Cancer survivorship and work. J Occup Rehabil. 2005;15:1–2.
7.
FeuersteinM.A Multidisciplinary Approach to the Prevention, Evaluation, and Management of Work Disability, J of Occup Rehab, 1991;1:5–12.
8.
van HakkaartRLSocietal Perspective on the Cost of Illness. Delft, Judels and Brinkman, 1998.
9.
HayesSBattistuttaDNewmanB.Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Can Res and Treatment. 2005;94:1–10.
10.
HewittMRowlandJHYancikR.Cancer Survivors in the United States: Age, Health, and Disability. J of Gerontology, 2003;58(1): 82–91.
11.
HladiukM.HuchcroftS.TempleW.SchnurrB., 1992. Arm function after axillary dissection for breast cancer: A pilot study to provide parameter estimates, Journal of Surgical Oncology. 50, 47–52.
12.
HuangGDFeuersteinM.Americans with Disabilities Act Litigation and Musculoskeletal-Related Impairments: Implications for Work Re-Entry. J of Occup Rehab, 1998;8:91–102.
13.
Institute of Medicine and National Research Council.From Cancer Patient to Cancer Survivor: Lost in Translation (2006). Washington, D.C.: National Academies Press.
14.
KesslerRCGreenbergPEMickelsonKDMeneadesLMWangPSThe effects of chronic medical conditions on work loss and work cutback. JOEM. 2001;43: 218–225.
15.
MainDSNowelsCTCavenderTAEtschmaierMSteinerJ.A Qualitative study of work and work return in cancer survivors. Psych-Oncology, 2005;14:992–1004.
16.
FanMar HGHouédé-TchenNYiGLChemerynskyIDownieFPSabateKTannockIFFatigue, Menopausal Symptoms, and Cognitive Function in Women After Adjuvant Chemotherapy for Breast Cancer: 1- and 2- Year Follow-Up of a Prospective Controlled Study. J Clin Oncol, 2005;23:8025–8032.
17.
McEvoyMDMcCorkleR.Quality of life issues in patients with disseminated breast cancer. Cancer, 1990 Sep 15;66(6S):1416–21.
National Cancer Institute (NCI). Estimated U.S. Cancer Prevelance (2005). [Online]. Available: http://cancercontrol.cancer.gov/ocs/ [accessed Feb. 10, 2006].
20.
OlderburgJFossaSDDahlAAScale for chemotherapy induced long term neurotoxicity: Psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual of Life Res. 2006;15: 791–800.
21.
PoppelreuterMWeisJKulzAKTuchaOLangeKWBartschHHCognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer. 2004;40(1):43–9.
22.
RietmanJSGeertzenJHBHoekstraHJBaasPDolsmaWVLong term treatment related upper limb morbidity and quality of life after sentinel node biopsy for stage I or II breast cancer. Eur J of Surg Oncol. 2006;32:148–152.
23.
ShortPFVaseyJJTunceliK.Employment Pathways in a Large Cohort of Adult Cancer Survivors. Cancer, 2005;103(6):1292–301.
24.
SpeltenERSprangersMAGVerbeekJHAMFactors reported to influence the return to work of cancer survivors: A literature review. Psycho-Oncology, 2002;11: 124–131.
25.
StoddardS.JansL.RippleJ.M.KrausL.Chartbook on Work and Disability in the United States: An Info Use Report. Washington, D.C.: National Institute on Disability and Rehabilitation Research, 1998.
26.
TaylorJCTerrellJERonisDLFowlerKEBishopCLambertMTMyersLLDuffySABradfordCRChepehaDBHogikyanNDPrinceMETeknosTNWolfGT; University of Michigan Head and Neck Cancer Team. Disability in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130(6):764–9.
27.
WefelJSLenziRTheriaultRLDavisRNMeyersCAThe Cognitive Sequelae of Standard-Dose Adjuvant Chemotherapy in Women with Breast Carcinoma Results of a Prospective, Randomized, Longitudinal Trial. Cancer2004;100:2292–9.
28.
YabroffKRLawrenceWFClauserSDavisWWBrownMLBurden of Illness in Cancer Survivors: Findings from a Population-Based National Sample, J National Cancer Institute, 2004;96(17): 1322–30.
